KATHERINE MENESES: Open Payments
NPI 1447727664 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 10 payments from 6 companies in 2025. Trend: 2023 $605 · 2024 $546 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $429 |
| Gilead Sciences, Inc. | 3 | $297 |
| Novo Nordisk Inc | 1 | $120 |
| Tempus AI, Inc | 1 | $97 |
| Bard Peripheral Vascular, Inc. | 1 | $37 |
| Medtronic, Inc. | 1 | $20 |
Products named: REZDIFFRA, Livdelzi, Wegovy, XT CDX, Ultraverse 014, ELLIPSYS VASCULAR ACCESS SYSTEM.
Industry payments across CA — which companies pay providers there.
